-
CME
DDW 2008: Biologic Therapy for Inflammatory Bowel Disease -- What Do the Latest Data Say?
Tune in to this video roundtable discussion, based on data from DDW 2008, to hear Drs. Hanauer, Mahadevan-Velayos, and Panaccione discuss the latest information on biologic therapy for IBD.
Roundtable, June 2008
-
Examining the Issues in Barrett's Esophagus: An Expert Interview With Prateek Sharma, MD
Prateek Sharma, MD, comments on the latest data about this clinically important lesion, with a view toward implications for screening and surveillance, as framed by data from DDW 2008.
Expert Interview, May 2008
-
Refining the Therapeutic Landscape in Anti-TNF Therapy for Crohn's Disease: An Expert Interview With David A. Schwartz, MD
David A. Schwartz, MD, discusses current and emerging issues in anti-TNF-alpha therapy for Crohn's disease, as framed by new data presented at DDW 2008.
Expert Interview, May 2008
-
Nonpolypoid Colorectal Neoplasms -- Prevalence and Association With Colorectal Cancer?
David A. Johnson, MD, provides clinical commentary on a recent article published in JAMA investigating the prevalence of NP-CRNs in a veterans population and characterizing their association with CRC.
Commentary, April 2008
-
Is Botulinum Toxin Effective Treatment for Delayed Gastric Emptying?
David Johnson, MD, provides clinical commentary on a recent article published in the Am J Gastroenterol assessing the efficacy of botulinum toxin for the treatment of delayed gastric emptying.
Commentary, April 2008
-
Management of Pain in Chronic Pancreatitis
The management of pain in chronic pancreatitis ranges from oral enzyme supplementation to neurosurgery; the approach depends on the pathophysiology of the pain.
Ask the Expert, April 2008
-
New Molecular Approaches to Hepatitis C: Focus on the Virus
Given the many challenges that remain in the treatment of HCV-infected patients, there is a pressing need for novel therapeutic options. Kris V. Kowdley, MD, FACP, discusses the state of the field.
Expert Column, March 2008
-
Can TNF Antagonists Alter the Natural History of Crohn's Disease: What Do the Data Tell Us?
Anti-TNF agents have reset the bar for what is an acceptable symptomatic response to therapy in Crohn's disease, allowing for the possibility of modifying the natural history of the disease itself.
Expert Column, March 2008
-
Pegylated Interferon for Chronic Hepatitis B
Is there any proposed practical road map for the treatment of chronic hepatitis B with pegylated interferon alfa-2a similar to the road map proposed for oral nucleoside/nucleotide analogs?
Ask the Expert, March 2008
-
Screening and Surveillance for Barrett's Esophagus in Patients With GERD
What are the current recommendations regarding screening and surveillance for Barrett's esophagus in patients with chronic reflux symptoms? Prateek Sharma, MD, explores the issue.
Ask the Expert, March 2008
